This Article Full Text Full Text (PDF) All Versions of this Article: 105/23/2772    most recent 01.CIR.0000017500.61563.80v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hamilton, A. Articles by McPherson, D. Search for Related Content PubMed PubMed Citation Articles by Hamilton, A. Articles by McPherson, D. Related Collections Cardiovascular imaging agents/Techniques Animal models of human disease Imaging Fibrinogen/fibrin Echocardiography

(Circulation. 2002;105:2772.)
© 2002 American Heart Association, Inc.

Basic Science Reports

Left Ventricular Thrombus Enhancement After Intravenous Injection of Echogenic Immunoliposomes

Studies in a New Experimental Model

Andrew Hamilton, MBBS; Shao-Ling Huang, PhD; Drew Warnick, BS; Adam Stein, BS; Mark Rabbat, BS; Taruna Madhav, BA; Bonnie Kane, BS; Ashwin Nagaraj, PhD; Melvin Klegerman, PhD; Robert MacDonald, PhD; David McPherson, MD

From the Department of Medicine, Northwestern University, Chicago, Ill (A.H., D.W., A.S., M.R., T.M., B.K., A.N., D.M.); Echodynamics, College Park, Md (M.K.); and the Department of Biochemistry, Molecular Biology, and Cell Biology, Northwestern University, Evanston, Ill (S.-L.H., R.M.).

Correspondence to Andrew Hamilton, Department of Medicine, Division of Cardiology, Northwestern University, Chicago, IL 60611-2908. E-mail a-hamilton{at}northwestern.edu

Background— Targeted echogenic immunoliposomes (ELIPs) for ultrasound enhancement of atheroma components have been developed. To date, ELIP delivery has been intra-arterial. To determine whether ELIPs can be given intravenously with enhancement of systemic structures, a left ventricular thrombus (LVT) model was developed.

Methods and Results— In 6 animals plus 1 dose-ranging animal, the apical coronary arteries were ligated, and an LVT was produced by injecting Hemaseel fibrin adhesive through the apical myocardium. The thrombus was imaged epicardially and transthoracically at 0, 1, 5, and 10 minutes after anti-fibrinogen ELIP injections. The dose of ELIPs was varied. PBS and unconjugated ELIPs were controls. The apical thrombi were easily reproduced and clearly visible with epicardial and transthoracic ultrasound. Enhancement occurred with 2 mg anti-fibrinogen ELIPs and increased with dose. With 8 mg ELIPs, enhancement was different from control within 10 minutes (P<0.05). Rhodamine-labeled anti-fibrinogen ELIPs were seen with fluorescence microscopy of the LVT. Blinded viewing detected enhancement by 10 minutes in all animals after anti-fibrinogen ELIPs.

Conclusions— We describe an easily reproducible LVT model. Anti-fibrinogen ELIPs delivered intravenously, as a single-step process, rapidly enhance the ultrasound image of a systemic target. This allows for future development of ELIPs as a targeted ultrasound contrast agent.

Key Words: echocardiography • contrast media • thrombus

This article has been cited by other articles:

				S.-L. Huang, P. H. Kee, H. Kim, M. R. Moody, S. M. Chrzanowski, R. C. MacDonald, and D. D. McPherson Nitric oxide-loaded echogenic liposomes for nitric oxide delivery and inhibition of intimal hyperplasia. J. Am. Coll. Cardiol., August 11, 2009; 54(7): 652 - 659. [Abstract] [Full Text] [PDF]

				S. Chumnanvej, M. J. Wood, T. E. MacGillivray, and M. F. V. Melo Perioperative Echocardiographic Examination for Ventricular Assist Device Implantation Anesth. Analg., September 1, 2007; 105(3): 583 - 601. [Abstract] [Full Text] [PDF]

				S. A. Wickline, A. M. Neubauer, P. Winter, S. Caruthers, and G. Lanza Applications of Nanotechnology to Atherosclerosis, Thrombosis, and Vascular Biology Arterioscler Thromb Vasc Biol, March 1, 2006; 26(3): 435 - 441. [Abstract] [Full Text] [PDF]

				G. E.R. Weller, M. K.K. Wong, R. A. Modzelewski, E. Lu, A. L. Klibanov, W. R. Wagner, and F. S. Villanueva Ultrasonic Imaging of Tumor Angiogenesis Using Contrast Microbubbles Targeted via the Tumor-Binding Peptide Arginine-Arginine-Leucine Cancer Res., January 15, 2005; 65(2): 533 - 539. [Abstract] [Full Text] [PDF]

				P. Hauff, M. Reinhardt, A. Briel, N. Debus, and M. Schirner Molecular Targeting of Lymph Nodes with L-Selectin Ligand-specific US Contrast Agent: A Feasibility Study in Mice and Dogs Radiology, June 1, 2004; 231(3): 667 - 673. [Abstract] [Full Text] [PDF]

				A. J. Hamilton, S.-L. Huang, D. Warnick, M. Rabbat, B. Kane, A. Nagaraj, M. Klegerman, and D. D. McPherson Intravascular ultrasound molecular imaging of atheroma components in vivo J. Am. Coll. Cardiol., February 4, 2004; 43(3): 453 - 460. [Abstract] [Full Text] [PDF]

				G. E.R. Weller, E. Lu, M. M. Csikari, A. L. Klibanov, D. Fischer, W. R. Wagner, and F. S. Villanueva Ultrasound Imaging of Acute Cardiac Transplant Rejection With Microbubbles Targeted to Intercellular Adhesion Molecule-1 Circulation, July 15, 2003; 108(2): 218 - 224. [Abstract] [Full Text] [PDF]